TY - JOUR

T1 - Niacin and contribution to normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

T2 - (Scientific Opinion)

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

AU - Tetens, Inge

AU - Sjödin, Anders Mikael

N1 - On request from the European Commission. Question No. EFSA-Q-2011-01231, adopted on 11 June 2015. European Food Safety Authority (EFSA), Parma, Italy

PY - 2015

Y1 - 2015

N2 - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to niacin and contribution to normal energy-yielding metabolism. The Panel considers that niacin, the food constituent that is the subject of the health claim, is sufficiently characterised. Contribution to normal energy-yielding metabolism is a beneficial physiological effect. The Panel has previously assessed a claim on niacin and contribution to normal energy-yielding metabolism with a favourable outcome. The target population was the general population. The Panel considers that the role of niacin in contributing to normal energy-yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of niacin and contribution to normal energy-yielding metabolism. The following wording reflects the scientific evidence: ‘Niacin contributes to normal energy-yielding metabolism.’ The target population is infants and young children up to three years of age.

AB - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to niacin and contribution to normal energy-yielding metabolism. The Panel considers that niacin, the food constituent that is the subject of the health claim, is sufficiently characterised. Contribution to normal energy-yielding metabolism is a beneficial physiological effect. The Panel has previously assessed a claim on niacin and contribution to normal energy-yielding metabolism with a favourable outcome. The target population was the general population. The Panel considers that the role of niacin in contributing to normal energy-yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of niacin and contribution to normal energy-yielding metabolism. The following wording reflects the scientific evidence: ‘Niacin contributes to normal energy-yielding metabolism.’ The target population is infants and young children up to three years of age.

KW - Faculty of Science

KW - Niacin

KW - Vitamin B3

KW - Infants

KW - Children

KW - Energy-yielding metabolism

KW - Health claims

U2 - 10.2903/j.efsa.2015.4180

DO - 10.2903/j.efsa.2015.4180

M3 - Journal article

VL - 13

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

IS - 7

M1 - 4180

ER -